Evvy, a female-founded startup that focuses on vaginal healthcare, has closed on a $14 million Series A funding round.
The round, led by Left Lane Capital, also includes General Catalyst and Labcorp Venture Fund, RH Capital, Ingeborg Investments, G9 Ventures, Virtue, and Amboy Street Ventures.
The funding will be used to scale access to Evvy’s testing and care platform, leverage AI to discover novel molecular signatures for women’s health diagnostics, and validate improved outcomes in fertility…